TIMI Risk Score for STEMI
Estimates all-cause mortality risk at 30 days in patients with ST-elevation myocardial infarction.
Introduction
Acute ST-elevation myocardial infarction (STEMI) remains a leading cause of morbidity and mortality worldwide. Timely risk assessment at presentation is critical—not only to guide immediate reperfusion strategies but also to inform prognosis, resource allocation, and secondary prevention planning. One widely used, validated clinical risk score for this purpose is the TIMI Risk Score for STEMI (also called the TIMI STEMI Score), developed by the Thrombolysis in Myocardial Infarction (TIMI) Study Group.
This article provides an overview of the TIMI STEMI Risk Score—its components, scoring methodology, clinical validation, interpretation, and utility in contemporary practice.
What Is the TIMI STEMI Risk Score?
The TIMI STEMI Risk Score is a simple, point-based clinical prediction model that estimates the 30-day all-cause mortality risk for patients presenting with STEMI. Unlike other scores (e.g., GRACE), it focuses exclusively on variables available at the earliest stage of presentation—often before definitive ECG or lab confirmation—making it especially useful in the pre-hospital, emergency department, or catheterization lab settings.
Components and Scoring
The score incorporates 7 independent predictors, each assigned 1 point (except one variable, which contributes up to 2 points), for a maximum possible score of 9. A patient is awarded 1 point for each present risk factor:
| Risk Factor | Points |
|---|---|
| Age ≥75 years | 3* |
| Systolic blood pressure <100 mm Hg | 2 |
| Heart rate >100 bpm | 2 |
| History of diabetes mellitus | 1 |
| History of hypertension | 1 |
| History of current tobacco use | 1 |
| Killip class II–IV (e.g., pulmonary rales, S3, cardiogenic shock) | 2 |
* Age ≥75 years contributes 3 points; all other factors contribute 1 or 2.
Note: Killip classification assesses clinical signs of heart failure:
- Class I: No clinical evidence of heart failure
- Class II: Mild (e.g., S3, rales, elevated JVP)
- Class III: Pulmonary edema (>50% lung fields involved)
- Class IV: Cardiogenic shock
Total score = sum of points for all present factors.
Risk Stratification and Predicted Mortality
The original validation study (Lee et al., Circulation 2004) linked the total score to predicted 30-day all-cause mortality:
| TIMI STEMI Score | Predicted 30-Day Mortality (%) |
|---|---|
| 0 | ~1.0% |
| 1 | ~2.3% |
| 2 | ~4.1% |
| 3 | ~7.1% |
| 4 | ~9.6% |
| 5 | ~13.7% |
| ≥6 | ~20.6% (up to 41% at score = 9) |
For example:
A 68-year-old smoker with SBP 95 mm Hg, HR 108 bpm, and Killip class II would score 2 + 2 + 1 + 2 = 7, carrying an estimated ~20.6% risk of death within 30 days.
These estimates have held up across multiple external validations—though absolute mortality has declined over time due to improvements in rapid reperfusion, antithrombotic therapy, and secondary prevention.
Clinical Validation and Evidence
- Original derivation/validation cohort: >8,200 patients with STEMI from the TIMI 14, PRAGUE-2, and other trials (Lee et al., Circulation 2004).
- The score was validated in both thrombolyzed and primary PCI-treated populations.
- It consistently demonstrates good discrimination, with C-statistics ranging from 0.75 to 0.83 for predicting 30-day mortality.
- Unlike biomarker-based scores, the TIMI STEMI Score relies solely on clinical variables, enhancing its utility in resource-limited or early presentation settings.
Strengths and Limitations
| ✅ Strengths | ❌ Limitations |
|---|---|
| ✔️ Simple to calculate—no labs/imaging needed | ✖️ Does not incorporate reperfusion timing, infarct size, or PCI success (e.g., TIMI flow post-PCI) |
| ✔️ Applicable in pre-hospital settings (e.g., by paramedics) | ✖️ Underestimates risk in younger patients without traditional risk factors but with large infarcts |
| ✔️ Validated across diverse geographic and healthcare settings | ✗️ Does not predict bleeding or other non-fatal outcomes |
| ✔️ Complements—not replaces—clinical judgment | ✗️ Less accurate than modern scores (e.g., Global Registry of Acute Coronary Events [GRACE] 2.0) in PCI-era cohorts |
How to Use It in Practice
- Upon initial contact: Gather history and vital signs—even before ECG confirmation.
- Calculate the score using the 7 variables.
- Interpret in context: A high score (>5) should heighten suspicion for large infarct burden, cardiogenic shock risk, or procedural complexity—and prompt aggressive hemodynamic support and rapid reperfusion.
- Integrate with other tools: Use alongside ECG findings (e.g., Q-wave location), troponin trends, and echocardiography—especially post-reperfusion—to refine prognosis.
💡 Tip: In patients undergoing primary PCI, some clinicians combine the TIMI STEMI Score with post-PCI TIMI flow for a more dynamic risk assessment.
Conclusion
The TIMI Risk Score for STEMI is an enduring tool for early, objective mortality risk stratification—especially valuable when time is limited and decision-making must be rapid. While newer biomarkers and imaging modalities have expanded our prognostic armamentarium, the simplicity, validity, and accessibility of this 9-point score ensure its continued relevance in both resource-rich and resource-constrained settings.
Ultimately, risk scores like TIMI do not dictate management alone—but they empower clinicians to personalize care, anticipate complications, and communicate risk effectively with patients and families.
References
- Lee KH, et al. Circulation. 2004;109(8):972–975. doi:10.1161/01.CIR.0000113629.85746.FE
- Antman EM, et al. JAMA. 2000;284(10):1296–1302. (TIMI Study Group methodology)
- Jolly SS, et al. Lancet. 2007;369(9562):591–598. (Global Registry of Acute Coronary Events [GRACE] comparison)
Disclaimer: This score is for educational purposes only and should not replace clinical judgment. Always confirm with institutional protocols and guidelines (e.g., ACC/AHA/ESC).
